ArticleiScience2026

AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis.

Guang-Shun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.